Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa by Miller, Candace M et al.
Why are antiretroviral treatment patients lost to follow-up?
A qualitative study from South Africa
Candace M. Miller
1, Mpefe Ketlhapile
2, Heather Rybasack-Smith
1 and Sydney Rosen
1,2
1 Center for Global Health and Development, Boston University, Boston, MA, USA
2 Health Economics and Epidemiology Research Ofﬁce, Wits Health Consortium, Themba Lethu Clinic, Johannesburg, South Africa
Summary objectives To better understand the reasons why patients default from antiretroviral treatment (ART)
programmes to help design interventions that improve treatment retention and ultimately, patient
outcomes.
methods Prospective cohort study at two treatment sites in South Africa followed by qualitative
interviews with patients that had defaulted.
results Respondents overwhelmingly reported that ART improved their health status and quality of
life. Nevertheless, despite improved health from taking ART and worse health when treatment is
stopped, serious barriers to treatment remained: transport costs, time needed for treatment, and logis-
tical challenges were barriers to treatment, whereas stigma around HIV⁄AIDS, and side effects associ-
ated with ART were less inﬂuential.
conclusion With a better understanding of the reasons for defaulting, interventions can be designed
that improve treatment retention and ultimately, patient outcomes. This study argues for realistic
interventions and policy changes designed to reduce the ﬁnancial and time burden of ART and to reduce
logistical barriers, such as simplifying the referral and transfer process, employing patient advocates, and
adopting extended and weekend clinic hours.
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Introduction
As large-scale programmes to provide antiretroviral treat-
ment (ART) for HIV⁄AIDS have expanded and matured in
sub-Saharan Africa, attention has shifted from a single-
minded focus on treatment access and initiation to the
broader set of long-term challenges in sustaining a vast and
complicated public health endeavour. One of these con-
cerns is retention of patients in care. ART is a lifelong
commitment that requires patients to adhere diligently to
daily medication dosing schedules and make frequent
clinic visits for care. Consistent with experiences in
treating chronic diseases globally, a systematic review of
patients who initiated ART across sub-Saharan Africa
found that approximately 25% were no longer in care
1 year after initiation, a ﬁgure rising to 40% after 2 years
(Rosen et al. 2007). Among this group of patients, a
minority had died, while the majority was classiﬁed as ‘lost
to follow up’.
Patients who discontinue treatment are at high risk of
illness and death because of AIDS-related conditions.
Consequently, many studies have attempted to quantify
and ascertain the status of patients reported as lost to
follow-up, including several in South Africa (MacPherson
et al. 2009, Dahab et al. 2008; Maskew et al. 2007). At a
large public hospital, 31% of patients who defaulted soon
after ART initiation had died, 25% had transferred and
44% had discontinued treatment voluntarily or could not
be found (Dalal et al. 2008). Another public sector clinic in
South Africa obtained similar results after tracing patients
who were at least 1 month late for their last clinic visit
6 months after starting ART: 41% had died, 7% had
transferred, and 52% had voluntarily discontinued
treatment or could not be found (Dahab et al. 2008).
Studies from other countries report similar outcomes after
actively tracing those initially reported as lost to follow-up
(Billy et al. 2007, Bisson et al. 2008, Tweya et al. 2009,
Geng et al. 2008, Krebs et al. 2008, Ochieng et al. 2007,
Yu et al. 2007).
A number of reasons for defaulting from treatment
programmes have been identiﬁed or hypothesized. These
include cost, transport and waiting time, stigma, family
pressures, religious beliefs and illness (Murray et al. 2009,
Aidi et al. 2009, Roura et al. 2009). Numerous studies in
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major cause of attrition in clinics, particularly those that
charge fees for services (Nachega et al. 2004; Maskew
et al. 2007; Dahab et al. 2008). Relocation is also a
common reason for dropout in South Africa, where the
population is highly mobile (Dahab et al. 2008).
To gain more insight into the reasons why patients
default from treatment programmes, and to suggest
actionable interventions to improve retention, we con-
ducted a prospective cohort study at two treatment sites in
South Africa, where more than half a million people were
receiving ART by the end of 2008 (UNAIDS 2008). We
conducted qualitative follow-up interviews with patients
who had defaulted from treatment to better understand
their reasons for defaulting. We conducted qualitative
follow-up interviews with patients who had defaulted from
treatment to better understand their reasons for defaulting.
Thus, patients may themselves help to identify interven-
tions that will foster long-term retention in care.
Methods
The subjects from this study were enrolled in a prospective
cohort of adult patients receiving ART at two treatment
centres in South Africa: an NGO clinic serving a rural
population in Limpopo Province and a large public
hospital in Gauteng Province. Patients were eligible for
enrolment if they (i) had initiated ART at least 6 months,
but no more than 3 years, before study recruitment, (ii)
were still on ART and (iii) were not more than 1 month
late for their most recent medication pickup or consulta-
tion.
After providing written consent, a random sample of
patients (n = 528) was enrolled in the study. Study
personnel administered a baseline questionnaire during a
routine clinic visit, collecting detailed contact information
for the patient. Twelve months after the baseline, clinic
medical records were reviewed to determine each subject’s
status. Status categories included (i) in care, (ii) defaulted,
(iii) died and (iv) transferred. Default was deﬁned as
being more than 1 month late for the next scheduled
consultation or medication pick up. Defaulting patients
were contacted and interviewed either face-to-face or by
telephone. Follow-up interviews were qualitative and
addressed the subject’s perceptions of the treatment and
clinic, current health status, and reasons for stopping
treatment, and also included an offer of assistance in
resuming treatment if the subject desired. For this analysis,
we focused solely on patients who had already defaulted
because our aim was to understand the immediate obsta-
cles facing such patients, and thus to help identify practical
interventions that can improve patient retention.
Data were analysed using NVIVO 8 software. Interviews
were read several times to identify major themes and ideas.
We also examined the consistency of ideas and experiences
within individual transcripts. Then a detailed list of
categories was created to reﬂect the major themes that
emerged from the interviews and the text from each
interview transcript was coded into the various categories.
Next, we examined the categories, noting the similarities
and differences within each category and quantifying the
frequency with which ideas occurred. We present qualita-
tive data using patients’ voices to describe their current
health status and reasons for defaulting or transferring.
Typical quotes are presented to illustrate the various
phenomena.
The study protocol was approved by the Boston
University Institutional Review Board and the Human
Research Ethics Committee (Medical) of the University of
the Witwatersrand.
Results
A total of 528 subjects were enrolled in the cohort,
including 291 from the urban public hospital and 237 from
the rural clinic. At both sites, these patients were almost
equally divided among those who had been on ART 6–12,
13–24 and 25–36 months at the time of enrolment. Twelve
months after enrolment, seven subjects had died, 25
subjects had been referred from the urban hospital to a
nearby primary care clinic, 16 had transferred to another
treatment site and 17 were more than 1 month late for
their last scheduled medication pickup or consultation and
were considered to have defaulted. Patients were eligible
for the qualitative study if they had defaulted on treatment
for more than 1 month. At the time of the interview,
defaulters were between 3 and 11 months beyond their
previously scheduled appointment (median = 7 months).
Transfer patients were interviewed 2–13 months
after their ﬁnal appointment at their initial clinic (med-
ian = 7 months). Fourteen of the defaulting patients and
all 16 transfers were interviewed regarding reasons for
default. Two of the defaulting subjects were not located and
one refused to be interviewed. Twelve defaulters reported
having stopped treatment at the time of the interview, and
two reported that they had re-started treatment at the
original clinic, after an interval of missed appointments.
In this analysis, we included both patients who trans-
ferred to new clinics on their own accord and patients who
stopped treatment. While transfer patients may successfully
remain in care at another site, their experience still
provides insight into the struggles and challenges that
antiretroviral (ARV) ARV patients face. We chose not to
interview patients who were down-referred from the urban
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are criteria for down-referral, and these patients thus have
better-than-average clinic attendance records.
In the larger random sample (n = 528), 75% of patients
were women. Among the qualitative sample of defaulters
and transfer patients, 65% were women (Table 1). In this
small qualitative sample, we found that compared to
transfer patients, defaulters were younger, more likely to
be woman and have higher levels of schooling, and they
were less likely to receive government grants or be
unemployed. The default rate in the study population was
similar between men (4%) and women (3%), and the
transfer rate was also similar (5% for men, 4% for
women).
Perceptions of treatment
Patients universally reported that they had experienced
important, even extraordinary health beneﬁts from taking
ART and recognized that stopping ART would lead to
illness. Weight gain and improved mobility were com-
monly noted:
The ARVs made me gain back my weight…even if I
have not gained it very much, they enabled me to
wake up again... (Female 31, defaulter 9 months)
I don’t know where to start when it comes to ARVs
because I feel I’m a person (again)…, People who saw
me when I was ill cannot believe what they see (now).
(Female 31, transfer patient)
The ARVs worked for me because they brought me
back to life, I feel different than before. At that stage I
was very, very, very sick…, so they gave me back my
life. (Female 36, defaulter 4 months)
Subjects also showed an understanding of the relation-
ships between ART and health, ART and CD4 counts, and
CD4 counts and illness.
ARVs are ﬁne if taken properly… I am sick because I
stopped. (Male 27, defaulter 10 months)
The difference is that when I was taking ARVs, I was
not sick, but now I am starting to feel a bit sick, my
bones and my arm are not well. (Male 40, defaulter
4 months)
Before I took them I was weak, I could not do
anything, take a walk like other people…now my
immune system is high…it is 800 and something…
from 123 in 2005. (Male 48, transfer patient)
Depending on their CD4 I will tell them to go and start
medication, and if they are sick, but if it is not too low
it is ﬁne not to start. (Male 34, defaulter 11 months)
In addition to improved health because of ARVs and
understanding the relationship between treatment and
health, most respondents reported that they would refer
family and friends for ART if needed. The respondents that
reported that they would advise others to take ARVs if
needed also demonstrated a high level of understanding of
the importance of remaining on treatment and taking pills
on time.
I will say that because I was sick, I was lying down
because of my sickness… and I woke up again, I will
tell them to drink ARVs in the right way and on time.
(Female 35, transfer patient)
Because I saw they work, they have power, as I was
told, and to use a condom and drink them accord-
ingly. (Male 29, transfer patient)
Current physical and mental health status
Among defaulting patients, seven of 14 reported experi-
encing negative physical health effects since stopping
treatment, although some reports were minor, such as a
worsened cough.
I left work actually early today, I was not feeling well,
I felt dizzy…, yes, it is also how I used to feel when I
started realizing I am HIV positive… I also had some
diarrhoea a bit since yesterday …(Male, 27, defaulter
10 months)
I’m ﬁne but not so ﬁne, my feet are painful and I have
a little coughing, I cannot go up the stairs, and it is
because I am not taking ARVs. When I was taking
ARVs I was ﬁne. (Female, 33, defaulter 8 months)
Table 1 Demographic background of study respondents
Default
patients
(n = 14)
Transfer
patients
(n = 16)
All
patients
(n = 28)
Age (mean years) 31 34 35
Gender (% male) 25 42 35
Level of schooling (% reaching
matriculation or beyond)
72 25 46
Receiving government grants (%) 8 44 29
Unemployed (%) 25 44 36
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is my temperature and I have headaches …(Female,
32, defaulter 2 months)
I don’t have anything that is a problem with my
health, I am still ﬁne. (Female, 36, defaulter
4 months)
A number commented about feeling stressed or worried,
because of pressures at home or at work or concern about
having stopped treatment.
My stress is that I cannot come to collect my
treatment…there is no pain in the my body, the
problem is I work in a mine and I cannot come to
the clinic because it is far (Male 40, defaulter
6 months)
Others reported, however, that they felt well both
physically and mentally.
All in all I am happy, except for some small things
that can cause stress…like employment, I have a lot of
work to do and I cannot cope… but I am generally
happy. (Female 24, defaulter 4 months)
Reasons for defaulting
All interviewees reported disclosure of their status to
others. In fact, all respondents, except for one transfer
patient, reported that they had someone in their household
who knew about their treatment. Respondents rarely
reported stopping medication because of family pressure or
stigma. Although one subject indicated that fear of stigma
in the workplace contributed to his inability to request
time off to collect medication, another respondent stated
that pressure and fear of disclosure did not affect her
decision:
One of the reasons I stopped treatment might be
because of [transportation] costs, but not side effects
or fear of disclosure, because there are people in my
street who know my status, and my friends. No, no
one has pressurized me to stop my pills. (Female 31,
defaulter 9 months)
Although the treatment sites did not charge for care,
several subjects had difﬁculty with transportation costs.
Of the 20 patients who transferred to new treatment
sites, 16 had lower transport costs to get to the new
clinic. Reduced transport costs and time were the main
reported reasons for transferring. Transfer patients were
more likely to be unemployed and be receiving govern-
ment grants than defaulters, suggesting that transport
costs were indeed an important consideration. Transfer
patients spent R22 (range R10–R200) on transportation
at baseline, a cost that fell to R12 per visit (range
R0–R46) at the new clinic. The median spent on
transportation by patients who defaulted was R13 (range
R0–R72).
Of the 14 defaulted patients, seven reported that
employment caused difﬁculties with obtaining medication.
Five reported that they could not take time off during the
regular clinic operating hours. Four reported a missed
appointment or medication pickup because of travel for
work or family-related events.
I was not able to go to the hospital because I started
at a new company and I could not take off…clinics
must be open over the weekend for people who work
… most people who do not turn up for their
appointments are working. (Male 34, defaulter
11 months)
I am 4 months without taking treatment, the main
reason being that I work Monday till Saturday, I
don’t have any other reason. Before I worked for a
different security company, and I could take off for 3
or 4 days, with this company there is no offs. (Female
31, defaulter 4 months)
Several patients cited missing paperwork, including
clinic cards, transfer papers, and proof of travel, as a
reason for missed appointments.
I lost my card and I was afraid to come to the clinic …
isn’t it that at the reception when you have no card
they tell you to go back …(Female 32, defaulter
2 months)
Several subjects reported abandoning treatment because
of long wait times, and there were reports of other health
systems concerns. Among the issues reported were long
queues, difﬁculty in booking appointments, difﬁculty
tracking down paperwork or staff, too many patients at
clinics, not enough time spent with providers, and clinics
running low on medication.
You see, Sisi, when you go to the hospital you have
to book … next you go to the clerks, but every time
there is a misunderstanding, they do not book you
on the appointment you agreed on. Even when you
try to make an appointment on the telephone, you
never know if they took your ﬁle out to book you on
the date you requested or not. And when you go
back you wait until 4 o’clock, they start telling you
that you did not book. (Female 36, defaulter
4 months)
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because my ﬁle is held by the social worker, I have
been there twice, I do not have money to be going up
and down and I walk there and back. If I want money
they (social workers) do not give me. (Female 33,
defaulter 8 months)
About the pills, sometimes they say there are no pills
and send me to the hospital but I am persevering, I
go there. (Female 37, defaulted on clinic visits
8 months, but reported obtaining pills from another
clinic)
They do not have the time for people, they only give
you what you need and then you go … (Female 36,
transfer patient)
Only two defaulted and ﬁve transferred patients reported
side effects. Of these, three complained of extremity pain,
one of eye discomfort and two of body shape changes. Two
women reported that side effects (body shape changes)
might be a contributing factor to default, although this was
not reported as a major barrier to treatment.
But they have advantages and disadvantages … there
are things that are hidden, like they deform you, they
changed my structure. (Female 36, defaulter
4 months)
[Regarding reasons for stopping ART] It can be
because of side effects with my breasts, they grew very
big (Female 32, defaulter 2 months)
The use of traditional medicine was not a major theme in
respondent reports, but it was mentioned by two subjects
as contributing to their decision to stop treatment. One
subject had stopped taking pills while in training to become
a sangoma (traditional healer).
I am not taking ARVs, I am just buying and drinking
my immune boosters … (Female 38, transfer patient)
I have been using Imbiza (traditional medicine) since I
stopped ARVs …, it was my mother who said we
must try the traditional healer because they said his
Imbiza helps …(Male 27, defaulter 10 months)
Finally, the belief that a positive attitude could directly
affect HIV progression and even effectiveness of ART was
prevalent in the interviews.
I see them (ARVs) as right, but you know…, they go
with the belief of a person and with the person’s body
… if a person believes that they will help they will, but
if a person is not trusting them, has a negative belief
about them, then they will not help them. (Female 24,
defaulter 4 months)
Discussion
We interviewed patients who had defaulted or transferred
at least 6 months after initiating ART, allowing us to focus
on longer-term reasons for discontinuing or changing
treatment among those who were at least initially suc-
cessful in their clinic attendance. Respondents over-
whelmingly reported that ART improved their health
status and quality of life. While most respondents associ-
ated declines in health to lack of ART, some treatment
defaulters reported no ill effects from stopping ART, which
may be because of the short time between defaulting and
the interviews.
Nevertheless, despite improved health from taking ART
and worse health when treatment is stopped, there were
still serious barriers to treatment. We found that transport
costs, time needed for treatment, and logistical challenges
were barriers to treatment, but that stigma and side effects
associated with ART were less inﬂuential.
In contrast to other studies in the literature, the cost of
medication was not an important barrier among respon-
dents because patients obtained ART and healthcare at
clinics free of charge. However, transfer patients reported
that transportation costs inﬂuenced treatment retention.
The majority of transfer patients lowered transportation
costs by changing clinic. Possible interventions to over-
come ﬁnancial barriers include providing stipends or
vouchers to patients to cover transport costs. Additionally,
a treatment plan designed to accommodate less frequent
appointments and drug pick up, such as every 3–6 months,
could reduce patient costs and reduce the time burden that
ART places upon patients.
Both transfer patients and defaulters described logistical
barriers to treatment. Many patients that had transferred
to other facilities for care reported that the referral
process was confusing. Without paperwork, patients
encountered difﬁculties in transferring to new clinics, and
needed to re-start treatment, placing undue burdens on
both patients and clinic staff. Given that patients may
need to transfer, simplifying the referral and transfer
process would enable the continuation of care for
patients, and minimize repetitive processes for overtaxed
staff.
All patients reported challenges related to clinic oper-
ating hours, paperwork and procedures. Respondents also
reported difﬁculty securing and changing appointments,
Tropical Medicine and International Health volume 15 suppl. 1 pp 48–54 june 2010
C. M. Miller et al. ART patient’s reasons for defaulting
52 ª 2010 Blackwell Publishing Ltd, 15 (Suppl. 1), 48–54inaccessible staff and long queues. Patients could not
always determine staff roles or the required procedures.
These uncertainties were insurmountable for some
patients without help from the interviewer, who helped
several patients return to treatment. A permanent staff
member who functioned like our interviewer might help
to bridge the gap between patients and staff. Extended
and weekend clinic hours would enable half of the
interviewees to remain compliant with ART. Even with
limited resources, Saturday and extended weekday hours
may be possible. Patients who travel would beneﬁt if
allowed to obtain larger supplies of medication, or to
temporarily obtain mediation from another clinic. Con-
venient ways to obtain medication and consistent,
streamlined processes would assist patients in remaining in
care.
Stigma did not emerge as an important reason for
defaulting from treatment. Similarly, traditional medica-
tion did not appear to interfere with ART for most
patients although several patients reported taking tradi-
tional medication both in addition to and as a substitute
for ART. Many patients reported feelings of stress, but
few associated their stress with a reduced capacity to
adhere to their medication regimen. Only one patient
reported that negative side effects led her to discontinue
treatment. Given the inclusion of stavudine, a drug
normally associated with a high burden of toxicities, in
ﬁrst-line ART in South Africa, this is an unexpected
ﬁnding.
We were able to locate and interview more than 90%
(30⁄33) of patients who defaulted or transferred 1 year
after study enrolment. The use of an interviewer ac-
quainted with local customs and culture was beneﬁcial in
both the quality of data gathered and the interpretation of
local euphemisms and expressions. The interviewer was
not able to validate information provided by some transfer
patients; however, and it is possible that some patients who
reported transferring had actually stopped treatment. As
the interviews were designed to investigate barriers to
treatment, however, patients who were unwilling to admit
default would probably still report their difﬁculties and
struggles with adherence. Inaccurate reports of transfer
might reﬂect deference to the interviewer or shame and
embarrassment.
With more insight into the reasons for defaulting and
transferring, interventions can be designed to improve ART
retention and ultimately, patient outcomes. This study
argues for interventions and policy changes designed to
reduce the ﬁnancial and time burden of ART and to reduce
logistical barriers, such as simplifying the referral and
transfer process, employing patient advocates, and adopt-
ing extended and weekend clinic hours.
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